Tratamiento farmacéutico en hospital sin necesidad de internamiento: responsabilidad del ISFAS o del Sistema de Salud; a propósito de la STS, Contencioso administrativo, de 1 de julio de 2020

  1. Juan José Fernández Domínguez
  2. Guillermo Domínguez Fernández
Revista General de Derecho del Trabajo y de la Seguridad Social

ISSN: 1696-9626

Year of publication: 2021

Issue: 59

Type: Article

More publications in: Revista General de Derecho del Trabajo y de la Seguridad Social


Índice Dialnet de Revistas

  • Year 2021
  • Journal Impact: 0.420
  • Field: DERECHO Quartile: C1 Rank in field: 42/355
  • Field: DERECHO DEL TRABAJO Quartile: C1 Rank in field: 8/37


  • Social Sciences: C

Journal Citation Indicator (JCI)

  • Year 2021
  • Journal Citation Indicator (JCI): 0.05
  • Best Quartile: Q4
  • Area: LAW Quartile: Q4 Rank in area: 390/417


The non-renewal of the Agreement signed in 1986, by which the INSS and the TGSS undertook to provide health care to ISFAS beneficiaries who exercised the option in this respect, has not ceased to provoke controversy. The time that has elapsed, and the substantial regulatory changes that have occurred, are fertile ground for a disagreement, that on this occasion concerns the pharmaceutical expenditure for this type of care provided on the basis of a dispensing order. The non-existence of this type of specialized care at the momento of the signature, together with the transfer of competences from the Social Security to the regional health systems, make the principle of equal treatment leads to demand for unification of doctrine on who has to bear the cost.